Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial

Aims: Bioactive adrenomedullin (bio-ADM) was recently shown to be a prognostic marker in patients with acute circulatory failure. We investigate the association of bio-ADM with organ injury, functional impairment, and survival in cardiogenic shock (CS). Methods: OptimaCC was a multicenter and random...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Koji, Levy, Bruno, Kimmoun, Antoine, Miró, Òscar, Duarte, Kévin, Asakage, Ayu, Blet, Alice, Deniau, Benjamin, Schulte, Janin, Hartmann, Oliver, Cotter, Gad, Davison, Beth A, Gayat, Etienne, Mebazaa, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509471/
https://www.ncbi.nlm.nih.gov/pubmed/34640526
http://dx.doi.org/10.3390/jcm10194512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509471/
https://www.ncbi.nlm.nih.gov/pubmed/34640526
http://dx.doi.org/10.3390/jcm10194512

Ejemplares similares